- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 31, 2025 | 10.74M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 9.04M sh |
| Capex | FY 2024 · Dec 31, 2023 | $29.11K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $7.48M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $26.92M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $88.19M |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $8.11M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $9.07M |
| Current Assets | FY 2024 · Dec 31, 2023 | $55.46M |
| Total Assets | FY 2024 · Dec 31, 2023 | $126.31M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$6.52 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$6.52 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $9.53M |
| Net Income | FY 2024 · Dec 31, 2023 | −$58.95M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$2.87M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $7.51M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $14.58M |
| Revenue | FY 2024 · Dec 31, 2023 | $22.09M |